NCT03192982

Brief Summary

To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 20, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

February 8, 2018

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

4.8 years

First QC Date

May 29, 2017

Last Update Submit

September 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction of wound complications in the foot pump group

    reduction from 18% to 14 %.Inspection of the operated leg at day 2 and 4 and at discharging. After discharging at 30 days, 6 month and one year.More frequent inspections can be necessary depending on the situation and the condition of the patient. Inspection of secretion from the operations cicatrices, necrosis and diastasis of the wounds, signs of infections, hematoma subcutaneously in the operation area, edema, temperature and color of the skin

    From randomization until 12 month examination (individual finish examination)

Secondary Outcomes (3)

  • Reduction of leg edema 50%,

    5 to 30 days

  • Time to mobilization in pump treated patients

    1 to 7 days

  • Length of stay in hospital

    10 to 14 Days

Study Arms (2)

Foot pump (A-V Impulse, 6000 Series)

EXPERIMENTAL

In OR before operation starts randomized to foot pump treatment post operative. Pump placed on foot immediately after operation is finished. Foot pump will be left on foot until full mobilization is reached

Device: A-V impulse 6000 Series

Standard treatment (compression)

ACTIVE COMPARATOR

In OR before operation starts randomized to standart treatment for edema after in situ bypass. Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg

Device: Standard treatment (compression)

Interventions

foot pad and pump

Foot pump (A-V Impulse, 6000 Series)

Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg

Standard treatment (compression)

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who need an insitu bypass from Common Femoral Artery to Popliteal AK/BK or crural Artery

You may not qualify if:

  • Ischemic wound that are located in such manner that compression of the foot is not possible. Former deep vein trombosis (DVT) or symptomatic post thrombotic syndrome (PTS) We only include patients without any connections to other studies-

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hans Ravn

Kolding, 6000, Denmark

RECRUITING

Related Publications (1)

  • Klit T, Dahl M, Houlind KC, Ravn H. Effect of Impulsive Compression Treatment on Postoperative Complications After Open Peripheral Vascular Revascularization (In Situ): Protocol for a Randomized Control Trial. JMIR Res Protoc. 2018 Feb 20;7(2):e58. doi: 10.2196/resprot.8799.

Study Officials

  • Hans Ravn, MD PhD

    Vejle Hospital

    STUDY CHAIR

Central Study Contacts

Hans Ravn, MD PhD

CONTACT

Kim C Houlind, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized prospective study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 29, 2017

First Posted

June 20, 2017

Study Start

February 8, 2018

Primary Completion

November 28, 2022

Study Completion

November 30, 2022

Last Updated

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

Locations